Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zecotek Photonics Inc. (ZMSPF)
Richmond, BC, CA
Zecotek Photonics Inc., a company dedicated to photonics technology, engineers and commercializes a diverse portfolio of photonics products and solutions. Its innovations serve various sectors across Canada, including medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering, industrial design, and multimedia. The firm operates through three primary divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. Key imaging systems developed by Zecotek encompass lutetium fine silicate scintillation crystals, solid-state micro-pixel avalanche photodiode photodetectors and transistors, and integrated detector modules. Beyond imaging, the company is also at the forefront of 3D display technology, offering glasses-free and auto-stereoscopic displays, as well as 3D printers and related advancements. Founded in 1983, Zecotek Photonics Inc. adopted its current name in November 2007, having previously been known as Zecotek Medical Systems Inc. Its corporate headquarters are located in Richmond, Canada.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -99.83% | -100.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Devices: +11.2%-44.3% Q2'20: +543.1% (vs Q2'19)
-
EPS growth Medical - Devices: +28.5%+8.8% Q2'20: +147.7% (vs Q2'19)
-
FCF margin FCF growth · Medical - Devices: +30.9%-5,109.1% Q2'20: +19.2% (vs Q2'19)
-
EBIT margin Medical - Devices: +6.2%-4,281.9% Q2'20: -967,584.2% (vs Q2'19)
-
ROIC Medical - Devices: +3.3%— Q2'20: +168,688.4% (vs Q2'19)
-
Share dilution Medical - Devices: 0.0%+1.6% Q2'20: +0.0% (vs Q2'19)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.92× Q2'20: -2.81× (vs Q2'19)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jul 2015 actual |
Jul 2016 actual |
Jul 2017 actual |
Jul 2018 actual |
Jul 2019 actual |
Jul 2020 actual |
Jul 2025 actual |
Jul 2026 1 Rev. Ana. 1 EPS Ana. |
Jul 2027 1 Rev. Ana. 1 EPS Ana. |
Jul 2028 1 Rev. Ana. 1 EPS Ana. |
Jul 2029 1 Rev. Ana. 1 EPS Ana. |
Jul 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
347.1K
est: 2.46M (-85.9%)
|
1.14M
est: 8.74M (-87.0%)
|
373.3K
est: 12.71M (-97.1%)
|
155.4K
est: 337.8K (-54.0%)
|
86.6K
est: 3.70M (-97.7%)
|
8.23M
est.
|
2.46M
est.
|
8.74M
8.74M – 8.74M
+255.4% YoY
|
12.71M
12.71M – 12.71M
+45.4% YoY
|
337.8K
337.8K – 337.8K
-97.3% YoY
|
3.70M
3.70M – 3.70M
+996.3% YoY
|
8.23M
8.23M – 8.23M
+122.4% YoY
|
| EBITDA |
-5.46M
est: -2.46M (-121.9%)
|
-4.01M
est: -8.74M (+54.1%)
|
-3.71M
est: -12.71M (+70.8%)
|
-6.64M
est: -337.8K (-1,865.5%)
|
-3.49M
est: -3.70M (+5.6%)
|
-8.23M
est.
|
-2.46M
est.
|
-8.74M
-8.74M – -8.74M
-255.4% YoY
|
-12.71M
-12.71M – -12.71M
-45.4% YoY
|
-337.8K
-337.8K – -337.8K
+97.3% YoY
|
-3.70M
-3.70M – -3.70M
-996.3% YoY
|
-8.23M
-8.23M – -8.23M
-122.4% YoY
|
| EBIT |
-7.13M
est: -2.46M (-189.9%)
|
-5.29M
est: -8.74M (+39.5%)
|
-3.25M
est: -12.71M (+74.4%)
|
-6.65M
est: -337.8K (-1,870.0%)
|
-3.71M
est: -3.70M (-0.1%)
|
-8.23M
est.
|
-2.46M
est.
|
-8.74M
-8.74M – -8.74M
-255.4% YoY
|
-12.71M
-12.71M – -12.71M
-45.4% YoY
|
-337.8K
-337.8K – -337.8K
+97.3% YoY
|
-3.70M
-3.70M – -3.70M
-996.3% YoY
|
-8.23M
-8.23M – -8.23M
-122.4% YoY
|
| Net Income |
-5.51M
est: -3.8K (-144,670.5%)
|
-4.02M
est: 2.5K (-159,053.7%)
|
-2.74M
est: 6.6K (-41,585.1%)
|
-3.80M
est: -3.8K (-99,877.6%)
|
-3.52M
est: -3.8K (-93,291.2%)
|
-2.5K
est.
|
-3.8K
est.
|
2.5K
2.5K – 2.5K
+166.5% YoY
|
6.6K
6.6K – 6.6K
+160.7% YoY
|
-3.8K
-3.8K – -3.8K
-157.6% YoY
|
-3.8K
-3.8K – -3.8K
+0.8% YoY
|
-2.5K
-2.5K – -2.5K
+34.7% YoY
|
| SGA |
4.48M
est: 45.67M (-90.2%)
|
3.10M
est: 162.31M (-98.1%)
|
2.76M
est: 236.07M (-98.8%)
|
4.63M
est: 6.27M (-26.2%)
|
3.47M
est: 68.75M (-95.0%)
|
152.89M
est.
|
45.67M
est.
|
162.31M
162.31M – 162.31M
+255.4% YoY
|
236.07M
236.07M – 236.07M
+45.4% YoY
|
6.27M
6.27M – 6.27M
-97.3% YoY
|
68.75M
68.75M – 68.75M
+996.3% YoY
|
152.89M
152.89M – 152.89M
+122.4% YoY
|
| EPS |
-49.03
est: -0.02 (-212,518.6%)
|
-33.35
est: 0.02 (-217,550.3%)
|
-20.44
est: 0.04 (-51,222.5%)
|
-23.40
est: -0.02 (-101,456.0%)
|
-21.34
est: -0.02 (-93,308.7%)
|
-0.01
est.
|
-0.02
est.
|
0.02
0.02 – 0.02
+166.5% YoY
|
0.04
0.04 – 0.04
+160.7% YoY
|
-0.02
-0.02 – -0.02
-157.6% YoY
|
-0.02
-0.02 – -0.02
+0.8% YoY
|
-0.01
-0.01 – -0.01
+34.6% YoY
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jiang Chen | Chief Financial Officer | 87.1K | male |
| Serge Khorev | Senior Vice President of Technology | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZMSPF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
